Provided by Tiger Trade Technology Pte. Ltd.

Syndax Pharmaceuticals

19.57
-0.0800-0.41%
Post-market: 19.590.0200+0.10%19:30 EDT
Volume:1.44M
Turnover:28.30M
Market Cap:1.75B
PE:-7.80
High:19.87
Open:19.70
Low:19.17
Close:19.65
52wk High:25.59
52wk Low:12.99
Shares:89.30M
Float Shares:80.30M
Volume Ratio:1.18
T/O Rate:1.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5100
EPS(LYR):-3.2949
ROE:-255.93%
ROA:-18.67%
PB:115.74
PE(LYR):-5.94

Loading ...

Is It Too Late To Consider Syndax Pharmaceuticals (SNDX) After A 116% One-Year Surge?

Simply Wall St.
·
Apr 15

Top 20 US Stocks by Trading Volume on April 14: Syndax Reaches New High, Year-to-Date Gain Exceeds 300%

Deep News
·
Apr 14

HBF Commercialization Accelerates: Sandisk to Launch Pilot Line in Second Half, Mass Production by Next Year

Deep News
·
Apr 13

Your Stock Just Doubled. What to Do Now. -- Barrons.com

Dow Jones
·
Apr 07

Syndax grants inducement stock options for up to 228,500 shares to new hires

Reuters
·
Apr 04

Is It Time To Reassess Syndax Pharmaceuticals (SNDX) After An 84% One Year Share Price Jump

Simply Wall St.
·
Apr 02

Syndax Pharmaceuticals Is Maintained at Buy by Goldman Sachs

Dow Jones
·
Apr 02

Micron, Other Memory Stocks Surge. Markets Are Back in Risk-On Mode. -- Barrons.com

Dow Jones
·
Apr 02

Syndax price target raised to $34 from $28 at Goldman Sachs

TIPRANKS
·
Mar 31

Jefferies Keeps Their Buy Rating on Syndax Pharmaceuticals (SNDX)

TIPRANKS
·
Mar 30

Mizuho Securities Sticks to Their Buy Rating for Syndax Pharmaceuticals (SNDX)

TIPRANKS
·
Mar 30

Assessing Whether Syndax Pharmaceuticals (SNDX) Still Looks Undervalued After Its Recent Strong Run

Simply Wall St.
·
Mar 15

Syndax Pharmaceuticals Is Maintained at Overweight by JP Morgan

Dow Jones
·
Mar 10

U.S. RESEARCH ROUNDUP-Dow, Oracle, Shopify

Reuters
·
Mar 09

Syndax Pharmaceuticals Inc : JP Morgan Raises Target Price to $45 From $33

THOMSON REUTERS
·
Mar 09

Syndax Pharmaceuticals’ Earnings Call Highlights Growth Push

TIPRANKS
·
Mar 08

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
Mar 05

Syndax Pharmaceuticals Is Maintained at Buy by Citigroup

Dow Jones
·
Mar 03

Syndax price target raised to $57 from $51 at Citi

TIPRANKS
·
Mar 02

Syndax’s Third FDA Win Accelerates Shift To Multi Product Revenues

Simply Wall St.
·
Mar 02